6832 studies found for:    Autoimmune
Show Display Options
Rank Status Study
21 Completed Steroid Therapy in Autoimmune Premature Ovarian Failure
Conditions: Autoimmune Disease;   Infertility;   Premature Ovarian Failure
Intervention:
22 Recruiting sPIF CLINICAL STUDY PROTOCOL FOR AUTOIMMUNE HEPATITIS
Condition: Autoimmune Hepatitis
Interventions: Drug: sPIF;   Drug: Placebo
23 Recruiting The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Other: Low Salt Diet;   Other: Liberal salt diet
24 Completed Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
Condition: Autoimmune Disease
Intervention:
25 Completed Oxidative Status in Children With Autoimmune Thyroiditis
Condition: Autoimmune Thyroiditis
Intervention: Other: measurement of oxidant status in AIT
26 Completed Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis
Condition: Autoimmune Thyroiditis
Intervention: Device: Low-level Laser therapy
27 Unknown  Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
Condition: Autoimmune Hepatitis
Intervention: Drug: Cyclosporine-A
28 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
29 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
30 Active, not recruiting Low Level Laser Therapy for Autoimmune Thyroiditis
Condition: Autoimmune Thyroiditis
Interventions: Procedure: Low-level laser therapy;   Procedure: Non laser ordinary red light
31 Completed Rituximab for Autoimmune Retinopathy
Condition: Autoimmune Disease
Intervention: Drug: Rituximab
32 Completed Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Conditions: Idiopathic Thrombocytopenic Purpura;   Anemia, Hemolytic, Autoimmune
Intervention: Drug: Alemtuzumab, Rituximab
33 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
34 Completed Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
Condition: Infections, Papillomavirus
Intervention: Other: Data collection
35 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide
36 Active, not recruiting Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease
Conditions: Myocardial Infarction;   Ischemic Stroke;   Stroke;   Subarachnoid Haemorrhage;   Venous Thrombosis;   Transient Ischemic Attack;   Stable Angina Pectoris;   Unstable Angina;   Heart Failure;   Peripheral Arterial Disease;   Abdominal Aortic Aneurysm
Intervention: Other: No intervention
37 Completed The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Conditions: Pemphigus;   Auto-immune Thrombocytopenic Purpura;   Hemolytic Auto-immune Anaemia;   Cold Agglutinin Disease;   Cryoglobulinemia
Intervention: Drug: Rituximab (MABTHERA® or RITUXAN®).
38 Unknown  Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases
Condition: Autoimmune Diseases
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
39 Recruiting A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Interventions: Drug: Fostamatinib 150 mg bid;   Drug: Fostamatinib 100 mg bid
40 Withdrawn Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)
Condition: Autoimmune Diabetes
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years